PAM
ENFN

Panagora Asset Management’s Enfusion, Inc. ENFN Stock Holding History

Panagora Asset Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,926
Closed -$710K – 1621
2021
Q4 		$710K Buy
+33,926
New +$686K ﹤0.01% 1073

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Panagora Asset Management's ENFN Position: Q1 2022 in Review

Panagora Asset Management sold out of Enfusion, Inc. (ENFN) in Q1 2022, closing a stake of 33,926 shares — an estimated $710K sold.

Panagora Asset Management first reported a position in ENFN in Q4 2021 and held it in 1 quarter. The position peaked at $710K in Q4 2021. 64 funds tracked by Wall St. Rank hold ENFN as of Q1 2022.

  • Panagora Asset Management reported no remaining Enfusion, Inc. position as of Q1 2022 after selling out during the quarter.
  • Panagora Asset Management sold 33,926 Enfusion, Inc. shares in Q1 2022, an estimated $710K.
  • Panagora Asset Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 1 quarter.
  • Panagora Asset Management's Enfusion, Inc. position peaked at $710K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2022.

Based on Panagora Asset Management's 13F filing for Q1 2022, filed 12 May 2022.